These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8697440)

  • 1. Mitochondrial DNA copy number changes in human gliomas.
    Liang BC; Hays L
    Cancer Lett; 1996 Aug; 105(2):167-73. PubMed ID: 8697440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for association of mitochondrial DNA sequence amplification and nuclear localization in human low-grade gliomas.
    Liang BC
    Mutat Res; 1996 Jul; 354(1):27-33. PubMed ID: 8692203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of transforming growth factor alpha in human gliomas.
    Schlegel U; Moots PL; Rosenblum MK; Thaler HT; Furneaux HM
    Oncogene; 1990 Dec; 5(12):1839-42. PubMed ID: 2284103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and tumoural heterogeneity of EGFR gene amplification in human malignant gliomas.
    Strommer K; Hamou MF; Diggelmann H; de Tribolet N
    Acta Neurochir (Wien); 1990; 107(3-4):82-7. PubMed ID: 2077857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma.
    Sonoda Y; Yoshimoto T; Sekiya T
    Oncogene; 1995 Nov; 11(10):2145-9. PubMed ID: 7478535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Instability of mitochondrial DNA and MRI and clinical correlations in malignant gliomas.
    Montanini L; Regna-Gladin C; Eoli M; Albarosa R; Carrara F; Zeviani M; Bruzzone MG; Broggi G; Boiardi A; Finocchiaro G
    J Neurooncol; 2005 Aug; 74(1):87-9. PubMed ID: 16078113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression and amplification of STK15 in human gliomas.
    Klein A; Reichardt W; Jung V; Zang KD; Meese E; Urbschat S
    Int J Oncol; 2004 Dec; 25(6):1789-94. PubMed ID: 15547718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA.
    Costello JF; Plass C; Arap W; Chapman VM; Held WA; Berger MS; Su Huang HJ; Cavenee WK
    Cancer Res; 1997 Apr; 57(7):1250-4. PubMed ID: 9102208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of epidermal growth factor receptor amplification in malignant gliomas.
    Sauter G; Maeda T; Waldman FM; Davis RL; Feuerstein BG
    Am J Pathol; 1996 Apr; 148(4):1047-53. PubMed ID: 8644846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
    Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
    BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coamplification of simple repetitive DNA fingerprint fragments and the EGFR gene in human gliomas.
    Nürnberg P; Zischler H; Fuhrmann E; Thiel G; Losanova T; Kinzel D; Nisch G; Witkowski R; Epplen JT
    Genes Chromosomes Cancer; 1991 Mar; 3(2):79-88. PubMed ID: 1676908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-resolution genome-wide mapping of genetic alterations in human glial brain tumors.
    Bredel M; Bredel C; Juric D; Harsh GR; Vogel H; Recht LD; Sikic BI
    Cancer Res; 2005 May; 65(10):4088-96. PubMed ID: 15899798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction of wild-type p53 enhances thrombospondin-1 expression in human glioma cells.
    Harada H; Nakagawa K; Saito M; Kohno S; Nagato S; Furukawa K; Kumon Y; Hamada K; Ohnishi T
    Cancer Lett; 2003 Feb; 191(1):109-19. PubMed ID: 12609716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors.
    Fleming TP; Saxena A; Clark WC; Robertson JT; Oldfield EH; Aaronson SA; Ali IU
    Cancer Res; 1992 Aug; 52(16):4550-3. PubMed ID: 1322795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Array CGH in brain tumors.
    Mohapatra G; Sharma J; Yip S
    Methods Mol Biol; 2013; 973():325-38. PubMed ID: 23412799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent loss of the cyclin-dependent kinase-4 inhibitor gene in human gliomas.
    Gomi A; Sakai R; Ogawa S; Shinoda S; Hirai H; Masuzawa T
    Jpn J Cancer Res; 1995 Apr; 86(4):342-6. PubMed ID: 7775255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amplification of alpha-platelet-derived growth factor receptor gene lacking an exon coding for a portion of the extracellular region in a primary brain tumor of glial origin.
    Kumabe T; Sohma Y; Kayama T; Yoshimoto T; Yamamoto T
    Oncogene; 1992 Apr; 7(4):627-33. PubMed ID: 1314366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of gene amplification and deletion in high-grade gliomas using a genome DNA microarray (GenoSensor Array 300).
    Sasaki T; Arai H; Beppu T; Ogasawara K
    Brain Tumor Pathol; 2003; 20(2):59-63. PubMed ID: 14756442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic alterations in brain tumors identified by RAPD analysis.
    Dil-Afroze ; Misra A; Sulaiman IM; Sinha S; Sarkar C; Mahapatra AK; Hasnain SE
    Gene; 1998 Jan; 206(1):45-8. PubMed ID: 9461413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refined mapping of 1q32 amplicons in malignant gliomas confirms MDM4 as the main amplification target.
    Riemenschneider MJ; Knobbe CB; Reifenberger G
    Int J Cancer; 2003 May; 104(6):752-7. PubMed ID: 12640683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.